Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

To Detect the Sensitivity of the UroMark Assay

NCT02781428

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tameside General Hospital Ashton-under-Lyne, United Kingdom
  • East Lancashire Hospitals NHS Trust Blackburn, United Kingdom
  • Royal Bolton Hospital Bolton, United Kingdom
  • The Pennine Acute Hospitals NHS Trust Bury, United Kingdom
View all 19 locations
View Trial Details

Related conditions